1887

Abstract

(MG) is an important poultry pathogen that causes respiratory disease and loss of production worldwide, and is currently controlled with live attenuated vaccines. These vaccines have limitations as they vary in their pathogenicity, the protection afforded and their transmissibility, but have been shown to effectively reduce losses associated with challenge in the field. A live attenuated vaccine, ts-11, has been used for the control of in several countries. This vaccine is highly dose-dependent and the flock antibody response is weak. GapA is the primary cytadherence molecule in , and the absence of GapA expression has been observed in the vast majority of cells in the ts-11 vaccine strain. In this study the immunogenicity of a GapA ts-11 vaccine was investigated in specific-pathogen-free chickens. Birds vaccinated with GapA ts-11 were protected against clinical signs of disease following challenge with virulent , and GapA ts-11 was shown to be non-pathogenic and more immunogenic at a lower dose than the currently available ts-11 vaccine. Thus, GapA ts-11 appears to have improved potential as a vaccine candidate.

Loading

Article metrics loading...

/content/journal/micro/10.1099/mic.0.046789-0
2011-06-01
2020-01-29
Loading full text...

Full text loading...

/deliver/fulltext/micro/157/6/1740.html?itemId=/content/journal/micro/10.1099/mic.0.046789-0&mimeType=html&fmt=ahah

References

  1. Devlin J. M., Viejo-Borbolla A., Browning G. F., Noormohammadi A. H., Gilkerson J. R., Alcami A., Hartley C. A.. ( 2010;). Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus. Vaccine28:1325–1332 [CrossRef][PubMed]
    [Google Scholar]
  2. García M., Ikuta N., Levisohn S., Kleven S. H.. ( 2005;). Evaluation and comparison of various PCR methods for detection of Mycoplasma gallisepticum infection in chickens. Avian Dis49:125–132 [CrossRef][PubMed]
    [Google Scholar]
  3. Gaunson J. E., Philip C. J., Whithear K. G., Browning G. F.. ( 2000;). Lymphocytic infiltration in the chicken trachea in response to Mycoplasma gallisepticum infection. Microbiology146:1223–1229[PubMed]
    [Google Scholar]
  4. Gaunson J. E., Philip C. J., Whithear K. G., Browning G. F.. ( 2006;a). The cellular immune response in the tracheal mucosa to Mycoplasma gallisepticum in vaccinated and unvaccinated chickens in the acute and chronic stages of disease. Vaccine24:2627–2633 [CrossRef][PubMed]
    [Google Scholar]
  5. Gaunson J. E., Philip C. J., Whithear K. G., Browning G. F.. ( 2006;b). Age related differences in the immune response to vaccination and infection with Mycoplasma gallisepticum . Vaccine24:1687–1692 [CrossRef][PubMed]
    [Google Scholar]
  6. Geary S. J., Gabridge M. G.. ( 1987;). Characterization of a human lung fibroblast receptor site for Mycoplasma pneumoniae . Isr J Med Sci23:462–468[PubMed]
    [Google Scholar]
  7. Geary S. J., Gabridge M. G., Intres R., Draper D. L., Gladd M. F.. ( 1989;). Identification of Mycoplasma binding proteins utilizing a 100 kilodalton lung fibroblast receptor. J Recept Res9:465–478[PubMed]
    [Google Scholar]
  8. Goh M. S., Gorton T. S., Forsyth M. H., Troy K. E., Geary S. J.. ( 1998;). Molecular and biochemical analysis of a 105 kDa Mycoplasma gallisepticum cytadhesin (GapA). Microbiology144:2971–2978 [CrossRef][PubMed]
    [Google Scholar]
  9. Kanci A., Browning G. F., Geary S. J., Papazisi L., Gorton T. S., Markham P. F.. ( 2004;) Is an unstable repeat sequence responsible for the attenuation of the Mycoplasma gallisepticum vaccine strain ts-11?. 15th Congress of the International Organization for Mycoplasmology
    [Google Scholar]
  10. Keeler C. L. Jr, Hnatow L. L., Whetzel P. L., Dohms J. E.. ( 1996;). Cloning and characterization of a putative cytadhesin gene (mgc1) from Mycoplasma gallisepticum . Infect Immun64:1541–1547[PubMed]
    [Google Scholar]
  11. Kleven S. H., Fan H. H., Turner K. S.. ( 1998;). Pen trial studies on the use of live vaccines to displace virulent Mycoplasma gallisepticum in chickens. Avian Dis42:300–306[CrossRef]
    [Google Scholar]
  12. Mohammed H. O., Carpenter T. E., Yamamoto R.. ( 1987;). Economic impact of Mycoplasma gallisepticum and M. synoviae in commercial layer flocks. Avian Dis31:477–482 [CrossRef][PubMed]
    [Google Scholar]
  13. Mudahi-Orenstein S., Levisohn S., Geary S. J., Yogev D.. ( 2003;). Cytadherence-deficient mutants of Mycoplasma gallisepticum generated by transposon mutagenesis. Infect Immun71:3812–3820 [CrossRef][PubMed]
    [Google Scholar]
  14. Noormohammadi A. H., Browning G. F., Cowling P. J., O’Rourke D., Whithear K. G., Markham P. F.. ( 2002;a). Detection of antibodies to Mycoplasma gallisepticum vaccine ts-11 by an autologous pMGA enzyme-linked immunosorbent assay. Avian Dis46:405–411 [CrossRef][PubMed]
    [Google Scholar]
  15. Noormohammadi A. H., Jones J. E., Underwood G., Whithear K. G.. ( 2002;b). Poor systemic antibody response after vaccination of commercial broiler breeders with Mycoplasma gallisepticum vaccine ts-11 not associated with susceptibility to challenge. Avian Dis46:623–628 [CrossRef][PubMed]
    [Google Scholar]
  16. Nunoya T., Tajima M., Yagihashi T., Sannai S.. ( 1987;). Evaluation of respiratory lesions in chickens induced by Mycoplasma gallisepticum . Nippon Juigaku Zasshi49:621–629[PubMed][CrossRef]
    [Google Scholar]
  17. Papazisi L., Troy K. E., Gorton T. S., Liao X., Geary S. J.. ( 2000;). Analysis of cytadherence-deficient, GapA-negative Mycoplasma gallisepticum strain R. Infect Immun68:6643–6649 [CrossRef][PubMed]
    [Google Scholar]
  18. Papazisi L., Frasca S. Jr, Gladd M., Liao X., Yogev D., Geary S. J.. ( 2002;). GapA and CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and virulence. Infect Immun70:6839–6845 [CrossRef][PubMed]
    [Google Scholar]
  19. Rodriguez R., Kleven S. H.. ( 1980;). Pathogenicity of two strains of Mycoplasma gallisepticum in broilers. Avian Dis24:800–807 [CrossRef][PubMed]
    [Google Scholar]
  20. Soeripto W., Whithear K. G., Cottew G. S., Harrigan K. E.. ( 1989;). Virulence and transmissibility of Mycoplasma gallisepticum . Aust Vet J66:65–72 [CrossRef][PubMed]
    [Google Scholar]
  21. Stipkovits L., Kempf I.. ( 1996;). Mycoplasmoses in poultry. Rev Sci Tech15:1495–1525[PubMed]
    [Google Scholar]
  22. Whithear K. G.. 1993; Avian mycoplasmosis. Australian Standard Diagnostic Techniques for Animal Diseases1–12 Corner L. A., Bagust T. J.. East Melbourne: CSIRO for the Standing Committee on Agriculture and Resource Management;
    [Google Scholar]
  23. Whithear K. G.. ( 1996;). Control of avian mycoplasmoses by vaccination. Rev Sci Tech15:1527–1553[PubMed]
    [Google Scholar]
  24. Whithear K. G., Soeripto, Harrigan K. E., Ghiocas E.. ( 1990;a). Immunogenicity of a temperature sensitive mutant Mycoplasma gallisepticum vaccine. Aust Vet J67:168–174 [CrossRef][PubMed]
    [Google Scholar]
  25. Whithear K. G., Soeripto, Harringan K. E., Ghiocas E.. ( 1990;b). Safety of temperature sensitive mutant Mycoplasma gallisepticum vaccine. Aust Vet J67:159–165 [CrossRef][PubMed]
    [Google Scholar]
  26. Yoshida S., Fujisawa A., Tsuzaki Y., Saitoh S.. ( 2000;). Identification and expression of a Mycoplasma gallisepticum surface antigen recognized by a monoclonal antibody capable of inhibiting both growth and metabolism. Infect Immun68:3186–3192 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/mic.0.046789-0
Loading
/content/journal/micro/10.1099/mic.0.046789-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error